Wellington Management Group’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-119,008
Closed -$396K 1961
2025
Q1
$396K Buy
119,008
+1,582
+1% +$5.27K ﹤0.01% 1845
2024
Q4
$869K Sell
117,426
-12,056
-9% -$89.2K ﹤0.01% 1724
2024
Q3
$1.22M Buy
129,482
+12,064
+10% +$113K ﹤0.01% 1659
2024
Q2
$942K Buy
117,418
+7,199
+7% +$57.7K ﹤0.01% 1680
2024
Q1
$1.63M Sell
110,219
-44,926
-29% -$666K ﹤0.01% 1570
2023
Q4
$1.26M Buy
155,145
+53,572
+53% +$436K ﹤0.01% 1581
2023
Q3
$462K Sell
101,573
-27,627
-21% -$126K ﹤0.01% 1708
2023
Q2
$910K Sell
129,200
-25,286
-16% -$178K ﹤0.01% 1618
2023
Q1
$944K Sell
154,486
-267,124
-63% -$1.63M ﹤0.01% 1671
2022
Q4
$2.69M Sell
421,610
-1,217,925
-74% -$7.78M ﹤0.01% 1433
2022
Q3
$15.7M Buy
1,639,535
+305,473
+23% +$2.93M ﹤0.01% 984
2022
Q2
$14.7M Sell
1,334,062
-9,954,664
-88% -$110M ﹤0.01% 1023
2022
Q1
$188M Buy
11,288,726
+1,704,644
+18% +$28.4M 0.03% 430
2021
Q4
$183M Buy
9,584,082
+684,552
+8% +$13.1M 0.03% 465
2021
Q3
$219M Buy
8,899,530
+1,648,287
+23% +$40.6M 0.04% 418
2021
Q2
$189M Buy
7,251,243
+3,586
+0% +$93.3K 0.03% 453
2021
Q1
$229M Buy
7,247,657
+1,635,725
+29% +$51.8M 0.04% 394
2020
Q4
$260M Buy
5,611,932
+4,964,622
+767% +$230M 0.05% 347
2020
Q3
$21.3M Sell
647,310
-2,122
-0.3% -$69.9K ﹤0.01% 941
2020
Q2
$17.8M Sell
649,432
-1,124,940
-63% -$30.9M ﹤0.01% 950
2020
Q1
$53.1M Sell
1,774,372
-629,332
-26% -$18.8M 0.01% 621
2019
Q4
$66.5M Buy
2,403,704
+1,255,069
+109% +$34.7M 0.01% 685
2019
Q3
$20.9M Buy
1,148,635
+761,258
+197% +$13.9M ﹤0.01% 950
2019
Q2
$9.5M Buy
+387,377
New +$9.5M ﹤0.01% 1230
2018
Q3
Sell
-63,237
Closed -$809K 2259
2018
Q2
$809K Sell
63,237
-8,548
-12% -$109K ﹤0.01% 1936
2018
Q1
$1.21M Buy
+71,785
New +$1.21M ﹤0.01% 1856